Rani Therapeutics News - RANI

Company Name	Stock Ticker Symbol	Market	Type
Rani Therapeutics Holdings Inc	RANI	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	0.00	0.00%	6.56	07:00:02

Open Price	Low Price	High Price	Close Price	Prev Close
				6.56

more quote information »

Recent News

Date	Time	Source	Heading
4/25/2024	8:52	IHNW	FeaturedCannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA
3/20/2024	16:05	GLOBE	Rani Therapeutics Reports Fourth Quarter and Full Year 2023..
3/15/2024	16:05	GLOBE	Rani Therapeutics to Report Fourth Quarter and Full Year..
2/05/2024	08:10	EDGAR2	Form 8-K - Current report
2/05/2024	08:00	GLOBE	Rani Therapeutics Announces Positive Topline Results from..
12/19/2023	16:06	EDGAR2	Form 8-K - Current report
12/19/2023	16:05	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/19/2023	16:05	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/19/2023	16:05	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/19/2023	16:05	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/19/2023	16:05	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/14/2023	08:05	EDGAR2	Form 8-K - Current report
12/14/2023	08:00	GLOBE	Rani Therapeutics Announces Preclinical Pharmacodynamic Data..
12/07/2023	17:18	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/06/2023	08:00	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/01/2023	08:00	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
11/08/2023	16:15	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/08/2023	16:10	EDGAR2	Form 8-K - Current report
11/08/2023	16:05	GLOBE	Rani Therapeutics Reports Third Quarter 2023 Financial..
11/01/2023	16:05	GLOBE	Rani Therapeutics Announces Strategic Program..
11/01/2023	16:04	EDGAR2	Form 8-K - Current report
10/25/2023	08:03	EDGAR2	Form 8-K - Current report
10/25/2023	08:00	GLOBE	The RaniPill® Capsule, Rani Therapeutics’ Oral Delivery..
10/19/2023	16:05	GLOBE	Rani Therapeutics Announces Successful Oral Delivery of..
10/12/2023	16:05	GLOBE	Rani Therapeutics to Present Abstract on RT-102 at the 2023..
9/18/2023	08:00	GLOBE	Rani Therapeutics Initiates Phase 1 Study of RT-111..
9/07/2023	17:04	EDGAR2	Form 8-K - Current report
9/07/2023	16:05	GLOBE	Rani Therapeutics Announces Successful Drug Delivery of..
9/06/2023	08:00	GLOBE	Rani Therapeutics to Participate in September Investor..
8/11/2023	16:10	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/11/2023	16:05	GLOBE	Rani Therapeutics Reports Second Quarter 2023 Financial..
8/08/2023	16:10	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/08/2023	16:05	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
8/04/2023	16:05	GLOBE	Rani Therapeutics to Participate in August Investor..
6/21/2023	08:00	GLOBE	Rani Therapeutics’ Presentation On Oral Delivery of PTH for..
6/08/2023	08:00	GLOBE	Rani Therapeutics Announces Acceptance of Late-Breaking..
6/05/2023	08:00	GLOBE	Rani Therapeutics and Celltrion Expand Partnership to..
6/01/2023	08:00	GLOBE	Rani Therapeutics to Present at the Jefferies Healthcare..
5/31/2023	08:00	GLOBE	Rani Therapeutics Announces Acceptance of Three Abstracts..
5/24/2023	08:00	GLOBE	Rani Therapeutics Appoints Kate McKinley as Chief Business..
5/10/2023	16:05	GLOBE	Rani Therapeutics Reports First Quarter 2023 Financial..